Author: healthylife7

ABILENE, Texas —A new study presented at the Endocrine Society’s ENDO 2026 annual meeting found that adults with obesity significantly reduced their physical activity while taking glucagon-like peptide-1 (GLP-1) receptor agonist medications for weight loss. Researchers analyzed wearable fitness tracker data from 753 participants and found that daily step counts fell by an average of…

Read More